EPO Patents = 1

Forward Citations = 174

Loading Chart...

2 inventors (with patents filed for the assignee):

Michael P Wallace (5 out of 149 patents)

Justin Panian (1 out of 11 patents)

Justin Panian (0 patent)

6 patents: Sort by Forward Citations

1. 11364043 - Methods and devices for endovascular therapy (2022-06-21),

2. 11116528 - Methods and devices for endovascular therapy (2021-09-14),

3. 11039845 - Methods and devices for endovascular therapy (2021-06-22),

4. 10980555 - Methods and devices for clots and tissue removal (2021-04-20),

5. 10959750 - Methods and devices for removing obstructing material from the human body (2021-03-30),

6. 9375223 - Methods and devices for endovascular therapy (2016-06-28),

Company Overview

Cardioprolific Inc. is a leading medical device company specializing in developing innovative solutions for cardiovascular diseases. Our mission is to improve patient outcomes and quality of life through cutting-edge technologies. We pride ourselves on our commitment to research and development, ensuring that our products are at the forefront of the industry. With a focus on excellence and innovation, Cardioprolific Inc. is dedicated to advancing the field of cardiology and transforming the future of healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#85 in Reno, NV

#403 in Nevada

#44,981 in US

Reno, NV, United States of America

Cardioprolific Inc.

Forward Citations = 174

2 inventors:

Michael P Wallace (5 out of 149 patents)

Justin Panian (1 out of 11 patents)

Justin Panian (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cardioprolific Inc.. Retrieved from https://idiyas.com/company/cardioprolific

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]